Risk-stratified CA125 screening integrating CA125 trajectories, trajectory-specific progression and transvaginal ultrasound for ovarian cancer

• Main Authors: Hongyuan Duan (Author), Xiaomin Liu (Author), Yu Zhang (Author), Ya Liu (Author), Yuting Ji (Author), Yunmeng Zhang (Author), Zeyu Fan (Author), Siwen Liu (Author), Lei Yang (Author), Tingting Xu (Author), Jing Tian (Author), Weiqin Li (Author), Zhangyan Lyu (Author), Fangfang Song (Author), Fengju Song (Author), Yubei Huang (Author)
• Format: Book
• Published: BMC, 2024-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Backgrounds Cancer antigen 125 (CA125) is widely used for screening ovarian cancer (OC), yet its effectiveness remains debated. Potential factors may include ineffective cut-off value for CA125 in screening, as well as a lack of consideration for CA125 trajectories and trajectory-specific p...